Nanocarrier– tag –
-
Stimuli-Responsive Biomimetic Nanomedicines Target Ischemic Stroke, Enhancing Therapeutic Efficacy via ROS Response
International Journal of Nanomedicine (IJN) International Overview This research focuses on stimuli-responsive biomimetic nanomedicines for targeted therapy in ischemic stroke, utilizing nanocarriers that respond to the elevated reactive... -
Oral GLP-1 Agonist Semaglutide Success Drives Peptide Drug Discovery Transformation: AI Design, Unnatural Amino Acids, and Nanocarriers Enhance Oral Bioavailability
Bhunia Lab Unknown Overview While peptide therapeutics have advanced significantly, oral delivery remains a challenge. The success of oral semaglutide demonstrates how chemical modifications like amino acid substitutions and fatty acid a... -
Hatch BioFund Invests in Optimeos Life Sciences: Coated Inverse Nanocarriers Achieve Over 90% Encapsulation Efficiency for Therapeutic Macromolecules
RegMedNet USA Overview Venture capital firm Hatch BioFund has invested in Optimeos Life Sciences, a Princeton University spinout, backing its proprietary nanoparticle platform for intracellular delivery of therapeutic macromolecules. Opt... -
Nanotechnology-Based Drug Delivery Systems Drive Personalized Medicine with Approved Formulations for Diverse Diseases
IJSRT Journal India Overview Nanotechnology-based Drug Delivery Systems (NDDS) have overcome limitations of conventional therapies by enhancing drug solubility, absorption, stability, and bioavailability, enabling targeted delivery to sp... -
Taylor & Francis Unveils Advanced Nanomedicine Strategies Revolutionizing Precision Therapeutics via Bioresponsive Materials, Lipid Nanoparticles, and Metal Nanostructures
Taylor & Francis Online (Article Collection) UK Overview Taylor & Francis has published an article collection highlighting advanced nanomedicine strategies that offer unprecedented control over pharmaceutical agent delivery, revoluti... -
Precision Nanodelivery of cGAS-STING Agonists Boosts Cancer Immunotherapy Efficacy
IJN (International Journal of Nanomedicine) ニュージーランド Overview Nanodrug delivery systems (nano-DDS) are transforming cancer immunotherapy by precisely delivering cGAS-STING pathway activators to tumors. These systems, ranging from... -
Precision Oncology Unleashed: Tumor-Specific Promoters and Nanocarriers Drive Next-Gen Gene Therapy, LNP-Based mRNA/siRNA Therapies Paving the Way
MDPI Switzerland Overview Precision cancer gene therapy is being transformed by the integration of tumor-specific promoters and nanodelivery systems, significantly enhancing therapeutic specificity. A range of nanocarriers, including LNP... -
Revolutionizing Skin Cancer Treatment with Nanoparticle-Enhanced Drug Delivery
DTU Research Database デンマーク Overview Nanoparticle-based biomaterials are transforming skin cancer treatment by significantly improving the dermal penetration and targeted delivery of anticancer drugs. These nanocarriers enhance drug...
12